E1 ReplicatedModerate confidencePEM unclearObservationalPeer-reviewedReviewed
Cytokine signature associated with disease severity in chronic fatigue syndrome patients
Jose G. Montoya, Tyson H. Holmes, Jill N. Anderson et al. · Proceedings of the National Academy of Sciences (PNAS) · 2017 · DOI
Quick Summary
Stanford researchers measured 51 cytokines in 192 ME/CFS patients and 392 healthy controls. Seventeen cytokines were significantly elevated in ME/CFS, with TGF-beta most strongly associated with disease severity. More severe patients had higher cytokine levels, suggesting immune activation scales with illness burden.
Why It Matters
This is one of the largest cytokine studies in ME/CFS and provides strong evidence for immune dysregulation correlated with symptom severity. The dose-response relationship between cytokine levels and severity strengthens the biological case for immune involvement.
Observed Findings
- Seventeen cytokines were significantly elevated in ME/CFS patients compared to 392 healthy controls
- TGF-beta showed the strongest association with disease severity
- Cytokine levels correlated with illness burden - more severe patients had higher cytokine levels
- Study measured 51 total cytokines across 192 ME/CFS patients
Inferred Conclusions
- Immune activation appears to scale with ME/CFS disease severity
- Cytokine dysregulation is a measurable feature of ME/CFS pathology
Remaining Questions
- Does cytokine dysregulation cause ME/CFS or is it a secondary response to underlying disease mechanisms?
- Are elevated cytokines specific to ME/CFS or do they occur in other inflammatory conditions with similar patterns?
- Could normalizing cytokine levels through intervention improve clinical outcomes?
What This Study Does Not Prove
Elevated cytokines are a feature of many inflammatory conditions. This study cannot show whether cytokine dysregulation causes ME/CFS or is a secondary response to the illness.
Tags
Method Flag:PEM_UNCLEARFUKUDA_CRITERIABIOLOGICALLY_RELEVANTExploratory OnlyWeak Case Definition
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Metadata
- DOI
- 10.1073/pnas.1710519114
- Case definition
- Fukuda 1994 Criteria
- Sample size
- 192 patients
- Control group
- Yes
- Review status
- Editor reviewed
- Evidence level
- Replicated human evidence from multiple independent studies
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.